Should brain-computer interfaces be regulated like medical devices or consumer tech?

As neural implants and brain-machine interfaces move from labs toward human trials, governments face decisions on how to classify and regulate them. Companies and researchers disagree on whether existing frameworks adequately protect users while enabling innovation.